Does DACLATASVIR Cause Interstitial lung disease? 21 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 21 reports of Interstitial lung disease have been filed in association with DACLATASVIR. This represents 0.4% of all adverse event reports for DACLATASVIR.
21
Reports of Interstitial lung disease with DACLATASVIR
0.4%
of all DACLATASVIR reports
2
Deaths
17
Hospitalizations
How Dangerous Is Interstitial lung disease From DACLATASVIR?
Of the 21 reports, 2 (9.5%) resulted in death, 17 (81.0%) required hospitalization, and 4 (19.0%) were considered life-threatening.
Is Interstitial lung disease Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for DACLATASVIR. However, 21 reports have been filed with the FAERS database.
What Other Side Effects Does DACLATASVIR Cause?
Fatigue (510)
Hepatocellular carcinoma (419)
Headache (411)
Hepatitis c (400)
Drug ineffective (385)
Treatment failure (310)
Nausea (287)
Anaemia (251)
Ascites (205)
Off label use (199)
What Other Drugs Cause Interstitial lung disease?
METHOTREXATE (3,049)
RITUXIMAB (2,458)
PEMBROLIZUMAB (2,113)
PREDNISONE (1,850)
CYCLOPHOSPHAMIDE (1,725)
NIVOLUMAB (1,538)
AMIODARONE (1,421)
DOXORUBICIN (1,352)
ETANERCEPT (1,267)
ADALIMUMAB (1,250)
Which DACLATASVIR Alternatives Have Lower Interstitial lung disease Risk?
DACLATASVIR vs DACLIZUMAB
DACLATASVIR vs DACOMITINIB
DACLATASVIR vs DACTINOMYCIN
DACLATASVIR vs DALBAVANCIN
DACLATASVIR vs DALFAMPRIDINE